相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term safety of monthly zoledronic acid therapy beyond 1year in patients with advanced cancer involving bone (LoTESS): A multicentre prospective phase 4 study
A. A. Khalafallah et al.
EUROPEAN JOURNAL OF CANCER CARE (2018)
Increased cathepsin K levels in human atherosclerotic plaques are associated with plaque instability (vol 14, pg 3471, 2017)
Huiying Zhao et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Pycnodysostosis: the disease of Henri de Toulouse-Lautrec
Konstantinos Markatos et al.
European Journal of Orthopaedic Surgery and Traumatology (2018)
Advances in the discovery of cathepsin K inhibitors on bone resorption
Jun Lu et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)
Role of the Bone Microenvironment in the Development of Painful Complications of Skeletal Metastases
Sun H. Park et al.
CANCERS (2018)
Cathepsin K Controls Cortical Bone Formation by Degrading Periostin
Nicolas Bonnet et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases
Enrico Munari et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2017)
Photoactivated inhibition of cathepsin K in a 3D tumor model
Mackenzie K. Herroon et al.
BIOLOGICAL CHEMISTRY (2016)
Cathepsin K osteoporosis trials, pycnodysostosis and mouse deficiency models: Commonalities and differences
Dieter Broemme et al.
EXPERT OPINION ON DRUG DISCOVERY (2016)
Cathepsin K knockout alleviates aging-induced cardiac dysfunction
Yinan Hua et al.
AGING CELL (2015)
Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer
Giorgio Gandaglia et al.
EUROPEAN UROLOGY (2015)
Cathepsin K: a unique collagenolytic cysteine peptidase
Marko Novinec et al.
BIOLOGICAL CHEMISTRY (2013)
Cathepsin K Knockout Mitigates High-Fat Diet-Induced Cardiac Hypertrophy and Contractile Dysfunction
Yinan Hua et al.
DIABETES (2013)
Cathepsin K Preferentially Solubilizes Matured Bone Matrix
Olivier Borel et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
Cathepsin K Expression and Activity in Canine Osteosarcoma
J. M. Schmit et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2012)
Bone cancer pain
Juan Miguel Jimenez-Andrade et al.
NEURONS AND NETWORKS IN THE SPINAL CORD (2010)
A cathepsin K inhibitor reduces breast cancer-induced osteolysis and skeletal tumor burden
Celine Le Gall et al.
CANCER RESEARCH (2007)
PTHrP-induced MCP-1 production by human bone marrow endothelial cells and osteoblasts promotes osteoclast differentiation and prostate cancer cell proliferation and invasion in vitro
Yi Lu et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
CCR2 expression correlates with prostate cancer progression
Yi Lu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption
Yi Lu et al.
CANCER RESEARCH (2007)
Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion
Yi Lu et al.
PROSTATE (2006)
Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice
L Wallner et al.
CANCER RESEARCH (2006)
Increased expression of osteopontin contributes to the progression of prostate cancer
AC Khodavirdi et al.
CANCER RESEARCH (2006)
A paradigm for the treatment of prostate cancer bone metastases based on an understanding of tumor cell-microenvironment interactions
RD Loberg et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Bisphosphonates induce inflammation and rupture of atherosclerotic plaques in apolipoprotein-E null mice
M Shimshi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Osteoprotegerin in prostate cancer bone metastasis
E Corey et al.
CANCER RESEARCH (2005)
Osteoblasts in prostate cancer metastasis to bone
CJ Logothetis et al.
NATURE REVIEWS CANCER (2005)
Glycogen synthase kinase-3β is involved in the phosphorylation and suppression of androgen receptor activity
TR Salas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors - A randomized, phase III, double-blind, placebo-controlled trial
LS Rosen et al.
CANCER (2004)
Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer
F Saad et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Cysteine cathepsins in human cancer
C Jedeszko et al.
BIOLOGICAL CHEMISTRY (2004)
Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases
SL Ruggiero et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2004)
Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic
RE Marx
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2003)
Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone
MP Roudier et al.
HUMAN PATHOLOGY (2003)
Cathepsin K mRNA and protein expression in prostate cancer progression
KD Brubaker et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
The ratio of messenger RNA levels of receptor activator of nuclear factor κB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis
NL Fazzalari et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone
J Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Metastatic patterns of prostate cancer:: An autopsy study of 1,589 patients
L Bubendorf et al.
HUMAN PATHOLOGY (2000)
分享论文
